P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
CA 2431362 A1 · Owner: Biosceptre International Limited · Inventors: Slater, Michael; Barden, Julian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods for identifying pre-neoplastic and neoplastic states in mammals and in particular to a method for identifying preneoplasia and neoplasia in cells and tissues based on differential expression of P2Y purinergic receptors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.